Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis

ConclusionIn a large cohort of patients with SSc ‐associated ILD, a significant proportion of patients had coexisting PH, which often occurs early after SSc diagnosis. Most patients were treated with ILD and PAH therapies, and survival was good. Patients with SSc‐associated ILD should be evaluated for coexisting PH.

Source: Arthritis and Rheumatology - June 17, 2019 Category: Rheumatology Authors: Amber Young, Dharshan Vummidi, Scott Visovatti, Kate Homer, Holly Wilhalme, Eric S. White, Kevin Flaherty, Vallerie McLaughlin, Dinesh Khanna Tags: Original Article Source Type: research